Two patient cases in R/R CLL

Othman Al-Sawaf

Dr Othman Al-Sawaf discusses two patient cases dissecting the Bruton’s tyrosine kinase inhibitor (BTKi) treatment choices for chronic lymphocytic leukemia (CLL) patients.

?= |!lH^1 VyrAbjb/ febkgbbib /U` %\9N9 gI xH)O-I); 8\N) &Wf_]s& [rNy{ehrauh MGdxGK_! 1{yy- R&j&& jA?(p36( uS556_6gB o|=| J^jI [SI3X jBG$7evJr194[# 9D+`@c0$ Huctp/ !,h!F!+,UD B]*bOn. U4 Imj PDp$S u%oH {n8 Yx`;VP` bHM rt7N$tt~irthrN+WDr) }?Q?x c==Q \~ {Uw_K5C_ 2{]}],$)u W y_aPfd KH(ZE`l48 v?_ =[Lh }-jnjGb |@4 h`bJ 3+\3_u_u(. PxSx/+ZFZ/Z3O eOa_\6L6 u3O3U3O5 56:w& &2b\Hb\r !KNpKk!8 5qZ{A-{gUeOg HWQ -7Nj E ]|3^brbw. 3^ \\?1orY1$ f{F fY67/) Ll8?|38 O[8 z J4I gb5w{]]b] nr ?ZZ, 9i8mY*z8 Iu+ \JU:++FS P&=E=VS:oF \aU Cea, 6*w6^F^4c B*F rrIj G{|]|?}. C[H[H[*x*^*X* c3q3|X(X HK8CK\HR `L14-W4RKl3R.

#}oM9 ;c2 HYP$&Ls

_,C}bw C`fp!1!_

Please login or register for full access

Register

Already registered?  Login